secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001493152-24-015820
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq deficiency notice for late 10-K filing; must file by Oct 14, 2024
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 18, 2024 for non-compliance with Listing Rule 5250(c)(1) due to late filing of Form 10-K for FY2023.
- Must submit a compliance plan by June 14, 2024 and file delinquent Form 10-K by October 14, 2024 to regain listing compliance.
- No immediate effect on stock trading, but further delays could impact listing; company intends to file as soon as practicable.
- Delay stems from previously disclosed issues with amended 10-Qs for first two quarters and 10-Q for third quarter of 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224015820/0001493152-24-015820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224015820/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer